MedTrace Logo

DBT for Smoking Cessation in High Risk Veterans

NCT06687577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2026-01-08

No results posted yet for this study

Summary

Individuals prone to suicidality are typically excluded from tobacco cessation interventions even though they are disproportionately likely to smoke, and even though smoking cessation has been linked to improved mood and reduced risk of suicide.

This trial enrolls Veteran smokers at high risk for suicide, and assigns them to receive either cessation treatment as usual, or a novel treatment that incorporates standard behavioral cessation treatment with Dialectical Behavior Therapy (DBT), an evidence-based treatment for suicide risk.

Conditions

  • Tobacco Dependence
  • Suicidal

Interventions

BEHAVIORAL

DBT-C

Tobacco cessation treatment adapted for high risk population.

BEHAVIORAL

Treatment as usual

Standard behavioral tobacco cessation treatment.

Sponsors & Collaborators

  • University of California

    collaborator OTHER

  • Veterans Medical Research Foundation

    lead OTHER

Principal Investigators

  • Neal M. Doran · Veterans Medical Research Foundation / VA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06687577 on ClinicalTrials.gov